EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mucoadhesive Peptide‐Catalase Self‐Assembled Nano‐Formulation for Effective Treatment of Mucosal Inflammatory Diseases

Xinzhu Li, Yuxuan Ma, Di He, Yingying Huang, Yutong Jiang, He Zhao, Shengjie Ge, Ruirui Zhao, Hejia Yuan, Wendi Jiang, Wenjun Zhu, Kai Liu und 2 weitere

Advanced Science · 2026-09 · 13 (54)

DOI: 10.1002/advs.76390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 02.07.2026. Verfasst von Xinzhu Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Catalase, Peptides, Inflammation, Mucous Membrane. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Programs of the Ministry of Science and Technology, Shenzhen Medical Research Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucosa, a vital interface between the body and external environment, often suffers from reactive oxygen burden within its microenvironment, leading to various mucosal inflammatory diseases. Drug delivery directly to inflamed mucosal regions offers a promising therapeutic approach, yet efficacy is compromised by inherent physiological clearance mechanisms. Herein, we developed a covalent mucoadhesive nanoantioxidant self‐assembled by a cysteine‐modified short peptide (CR 8 L 10 ) and catalase (CAT) for the treatment of mucosal inflammatory diseases. The obtained CR 8 L 10 @CAT nanocomplexes with a cysteine‐decorated surface enable robust mucoadhesion by forming dynamic disulfide bonds with mucin‐rich mucosa, leading to significantly enhanced CAT retention. Upon intravesical instillation, CR 8 L 10 @CAT with improved urine‐resistant bladder retention, could be used to treat hard‐to‐manage interstitial cystitis/bladder pain syndrome (IC/BPS). Notably, intravesically administered CR 8 L 10 @CAT effectively eliminated excessive reactive oxygen species (ROS) in the bladder mucosa, thereby inhibiting pro‐inflammatory responses, restoring urothelial integrity, and alleviating pain and voiding dysfunction, demonstrating significantly better analgesic effects and superior functional improvement than clinically used intravesical agents. Additionally, inhalation of the mucoadhesive CR 8 L 10 @CAT nanoantioxidant also showed enhanced pulmonary retention to effectively mitigate ROS‐associated inflammation in treating acute lung injury (ALI). This mucoadhesive CR 8 L 10 @CAT nanoantioxidant represents an effective therapeutic strategy to manage different mucosal inflammatory diseases, holding great promise for clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CatalasePeptidesInflammationMucous MembraneNanoparticlesCystitis, InterstitialAnimalsReactive Oxygen SpeciesHumansFemale

Stichwörter der Autor:innen

acute lung injuryinflammationinterstitial cystitislocal administrationmucoadhesionreactive oxygen species

Substanzen

CatalasePeptidesReactive Oxygen Species

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu, China.
  • College of Pharmaceutical Science, Soochow University, Suzhou, Jiangsu, China.
  • Wisdom Lake Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.
  • Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.

Förderung

  • Key Research and Development Programs of the Ministry of Science and Technology
  • Shenzhen Medical Research Fund
  • National Natural Science Foundation of China
  • National Technology Innovation Center for Biopharmaceuticals
  • Jiangsu Key R&D Program
  • Collaborative Innovation Center of Suzhou Nano Science and Technology
  • 111 Program from the Ministry of Education of China
  • New Cornerstone Science Foundation

Zitieren

APA

Li, X., Ma, Y., He, D., Huang, Y., Jiang, Y., Zhao, H., Ge, S., Zhao, R., Yuan, H., Jiang, W., Zhu, W., Liu, K., Zhang, H., & Liu, Z. (2026). Mucoadhesive Peptide‐Catalase Self‐Assembled Nano‐Formulation for Effective Treatment of Mucosal Inflammatory Diseases. Advanced Science, 13(54). https://doi.org/10.1002/advs.76390

Vancouver

Li X, Ma Y, He D, Huang Y, Jiang Y, Zhao H, et al. Mucoadhesive Peptide‐Catalase Self‐Assembled Nano‐Formulation for Effective Treatment of Mucosal Inflammatory Diseases. Advanced Science. 2026;13(54). doi:10.1002/advs.76390

BibTeX
@article{Li2026,
  author = {Li, Xinzhu and Ma, Yuxuan and He, Di and Huang, Yingying and Jiang, Yutong and Zhao, He and Ge, Shengjie and Zhao, Ruirui and Yuan, Hejia and Jiang, Wendi and Zhu, Wenjun and Liu, Kai and Zhang, Han and Liu, Zhuang},
  title = {Mucoadhesive Peptide‐Catalase Self‐Assembled Nano‐Formulation for Effective Treatment of Mucosal Inflammatory Diseases},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {54},
  doi = {10.1002/advs.76390}
}
Kostenlos starten →